UWS
GILD icon

Unique Wealth Strategies’s Gilead Sciences GILD Stock Holding History

Unique Wealth Strategies’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,326
Closed -$591K – 238
2025
Q3 		$591K Sell
5,326
-43
-0.8% -$4.89K 0.23% 139
2025
Q2 		$595K Buy
5,369
+98
+2% +$10.4K 0.25% 113
2025
Q1 		$591K Sell
5,271
-1,316
-20% -$136K 0.27% 92
2024
Q4 		$608K Buy
+6,587
New +$593K 0.26% 90
2024
Q3 		– Sell
-76
Closed -$5.57K – 390
2024
Q2 		$5.57K Buy
+76
New +$5.07K ﹤0.01% 382

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Unique Wealth Strategies's GILD Position: Q4 2025 in Review

Unique Wealth Strategies sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 5,326 shares — an estimated $591K sold.

Unique Wealth Strategies first reported a position in GILD in Q2 2024 and held it in 5 quarters. The position peaked at $608K in Q4 2024. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Unique Wealth Strategies reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Unique Wealth Strategies sold 5,326 Gilead Sciences shares in Q4 2025, an estimated $591K.
  • Unique Wealth Strategies first reported a position in Gilead Sciences in Q2 2024 and held it in 5 quarters.
  • Unique Wealth Strategies's Gilead Sciences position peaked at $608K in Q4 2024.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Unique Wealth Strategies's 13F filing for Q4 2025, filed 14 Jul 2026.